The pro-inflammatory marker soluble suppression of tumorigenicity-2 (ST2) is reduced especially in diabetic morbidly obese patients undergoing bariatric surgery
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2840
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The pro-inflammatory marker soluble suppression of tumorigenicity-2 (ST2) is reduced especially in diabetic morbidly obese patients undergoing bariatric surgery ; volume:19 ; number:1 ; day:26 ; month:2 ; year:2020 ; pages:1-9 ; date:12.2020
Cardiovascular diabetology ; 19, Heft 1 (26.2.2020), 1-9, 12.2020
- Creator
-
Demyanets, Svitlana
Kaun, Christoph
Kaider, Alexandra
Speidl, Walter
Prager, Manfred
Oravec, Stanislav
Hohensinner, Philipp
Wojta, Johann
Rega-Kaun, Gersina
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12933-020-01001-y
- URN
-
urn:nbn:de:101:1-2020052023565180347845
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Demyanets, Svitlana
- Kaun, Christoph
- Kaider, Alexandra
- Speidl, Walter
- Prager, Manfred
- Oravec, Stanislav
- Hohensinner, Philipp
- Wojta, Johann
- Rega-Kaun, Gersina
- SpringerLink (Online service)
Other Objects (12)
Copeptin und Suppressor-of-Tumorigenicity 2 (ST2) bei der Rechtsherzinsuffizienz
Evaluation of soluble suppression of tumorigenicity 2 (sST2) as serum marker for liver fibrosis
Micronutrient status in morbidly obese patients undergoing bariatric surgery – assessment and intervention
Cushing's Syndrome in a Morbidly Obese Patient Undergoing Evaluation before Bariatric Surgery
Quantification of epicardial adipose tissue in morbidly obese patients before and after bariatric surgery
Roux-en-Y-Bariatric Surgery Reduces Markers of Metabolic Syndrome in Morbidly Obese Patients
Bariatric surgery in morbidly obese individuals affects plasma levels of protein C and thrombomodulin
Psychological Correlates to Dysfunctional Eating Patterns among Morbidly Obese Patients Accepted for Bariatric Surgery
Archivauskunft ST2
Comparative Analysis of Mortality Rates among Morbidly Obese Individuals: A Study of Patients Undergoing Bariatric Surgery, Nonsurgical Morbidly Obese Individuals, and the General Population
Changes in plasma aldosterone level after weight loss by bariatric surgery in morbidly obese patients
The pessimist (morbidly)
Copeptin und Suppressor-of-Tumorigenicity 2 (ST2) bei der Rechtsherzinsuffizienz
Evaluation of soluble suppression of tumorigenicity 2 (sST2) as serum marker for liver fibrosis
Micronutrient status in morbidly obese patients undergoing bariatric surgery – assessment and intervention
Cushing's Syndrome in a Morbidly Obese Patient Undergoing Evaluation before Bariatric Surgery
Quantification of epicardial adipose tissue in morbidly obese patients before and after bariatric surgery
Roux-en-Y-Bariatric Surgery Reduces Markers of Metabolic Syndrome in Morbidly Obese Patients
Bariatric surgery in morbidly obese individuals affects plasma levels of protein C and thrombomodulin
Psychological Correlates to Dysfunctional Eating Patterns among Morbidly Obese Patients Accepted for Bariatric Surgery
Archivauskunft ST2
Comparative Analysis of Mortality Rates among Morbidly Obese Individuals: A Study of Patients Undergoing Bariatric Surgery, Nonsurgical Morbidly Obese Individuals, and the General Population
Changes in plasma aldosterone level after weight loss by bariatric surgery in morbidly obese patients
The pessimist (morbidly)
Copeptin und Suppressor-of-Tumorigenicity 2 (ST2) bei der Rechtsherzinsuffizienz
Evaluation of soluble suppression of tumorigenicity 2 (sST2) as serum marker for liver fibrosis
Micronutrient status in morbidly obese patients undergoing bariatric surgery – assessment and intervention
Cushing's Syndrome in a Morbidly Obese Patient Undergoing Evaluation before Bariatric Surgery
Quantification of epicardial adipose tissue in morbidly obese patients before and after bariatric surgery
Roux-en-Y-Bariatric Surgery Reduces Markers of Metabolic Syndrome in Morbidly Obese Patients
Bariatric surgery in morbidly obese individuals affects plasma levels of protein C and thrombomodulin
Psychological Correlates to Dysfunctional Eating Patterns among Morbidly Obese Patients Accepted for Bariatric Surgery
Archivauskunft ST2
Comparative Analysis of Mortality Rates among Morbidly Obese Individuals: A Study of Patients Undergoing Bariatric Surgery, Nonsurgical Morbidly Obese Individuals, and the General Population
Changes in plasma aldosterone level after weight loss by bariatric surgery in morbidly obese patients